Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...

Learn More

Making a Difference for Patients

Meet the Colorado Leaders Developing Breakthrough Cures and Treatments Colorado’s researchers, innovators and entrepreneurs work to develop breakthroughs start locally and impact globally. Our sector’...

Learn More

Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...

Learn More

Prescription Drugs: Just the Facts

As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription...

Learn More

Weekly Policy Update: Action on Two Bills and Advocacy in DC

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

Learn More

Colorado BioScience Association Names New Board Members

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...

Learn More

Driving Down Drug Costs

Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...

Learn More

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Learn More

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...

Learn More

Understanding Bills at the Legislature

Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...

Learn More